Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Non-Melanoma Skin Cancer Market: Focus on Disease Indication, Treatment Type, Country and Region, 2025-2035

GlobeNewswire

The global non-melanoma skin cancer (NMSC) market is growing as basal cell carcinoma and squamous cell carcinoma rates rise due to UV exposure and aging populations. Advanced diagnostics, AI, targeted therapies, superficial radiation therapy and electronic brachytherapy are improving early detection and outcomes. North America leads the market, followed by Europe, while Asia-Pacific is expanding rapidly. Key players include Amgen, Regeneron, Almirall and Boehringer Ingelheim. FDA-approved Libtayo is also strengthening treatment options for cutaneous squamous cell carcinoma. The global non-melanoma skin cancer (NMSC) market is growing as basal cell carcinoma and squamous cell carcinoma rates rise due to UV exposure and aging populations. Advanced diagnostics, AI, targeted therapies, superficial radiation therapy and electronic brachytherapy are improving early detection and outcomes. North America leads the market, followed by Europe, while Asia-Pacific is expanding rapidly. Key players include Amgen, Regeneron, Almirall and Boehringer Ingelheim. FDA-approved Libtayo is also strengthening treatment options for cutaneous squamous cell carcinoma.

  1. FinanceROSEN, REGARDED INVESTOR COUNSEL, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASTSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the “Class Period”), of the important November 13, 2026 lead plaintiff deadline.
  2. FinanceROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fluence Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLNCWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fluence Energy, Inc. (NASDAQ: FLNC) between November 24, 2025 and September 16, 2026, inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline.
  3. AIDiscoverSTEM DallasShalaan Umar is America’s Top Young Innovator 2026 as Young Inventors Earn Global Recognition for Breakthrough InnovationsDiscoverSTEM Foundation celebrates young innovators across the United States and UAE, recognizing pioneering achievements in healthcare, artificial intelligence, aerospace, sustainability, and engineering.
  4. FinanceCELH DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Celsius Holdings, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - CELHWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Celsius Holdings, Inc. (NASDAQ: CELH) between February 21, 2025 and June 3, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026 lead plaintiff deadline.
  5. FinanceRxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesRxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight’s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight’s common stock to the same employees in connection with the commencement of their employment with RxSight, which RSUs are anticipated to be granted on or about November 3, 2026.
  6. FinanceDKS IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DICK’S Sporting Goods, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DKSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DICK’S Sporting Goods, Inc. (NYSE: DKS) between September 8, 2025 and August 24, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026 lead plaintiff deadline.